文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

Preloop试验:一项随机对照试验的研究方案

Preloop trial: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-11-09

Preloop试验为前瞻性、随机、对照、多中心试验,比较合成补片(Parietene Macro)与生物植入物(Permacol)在回肠襻式造口还纳术中置入腹膜后肌下层的效果,主要终点为30天感染和造口还纳后10个月临床或CT诊断的切口疝发生率,计划1:1随机100例患者。

要点

  • 比较合成补片与生物补片预防造口还纳后切口疝。
  • 主要终点为30天感染和10个月切口疝发生率。
  • 计划随机100例,1:1分组。

核心结论

  • 该试点试验旨在为合成补片与生物植入物预防回肠襻式造口还纳后切口疝的安全性及有效性提供新证据。
  • 假设合成补片经济、安全且至少与生物植入物在预防疝及污染手术部位同样有效。

研究设计与样本

  • 前瞻性、随机、对照、多中心试验(ClinicalTrials NCT03445936)。
  • 比较合成补片(Parietene Macro™)与生物植入物(Permacol™)置于腹膜后肌下层。
  • 计划1:1随机共100例患者。

主要发现

  • 原文未报告试验结果。

关键数值与推荐

  • 主要终点:30天随访感染和造口还纳后10个月临床或CT扫描诊断的疝发生率。
  • 次要终点:术后30天内其他并发症(Clavien-Dindo分级)、再手术率、手术时间、住院时间、RAND-36生活质量及5年随访疝发生率。

临床怎么用

  • 为造口还纳术中补片选择提供试点证据,尚待结果验证。

局限性

  • 为试点试验,样本量100例,结果需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A temporary loop ileostomy, which is used to decrease the risk of symptomatic anastamotic leakage after anterior resection and total mesorectal excision (TME), is traditionally closed without any mesh. However, as 44% of incisional site hernias need further repair after stoma closure, attention has increasingly been paid to the use of mesh. Research on the prevention of these hernias is scarce, and no studies comparing different meshes exist. METHOD/DESIGN: The Preloop trial (Clinical Trials NCT03445936) is a prospective, randomized, controlled, multicenter trial to compare synthetic mesh (Parietene Macro™, Medtronic, Minneapolis, MN, USA) and biological implants (Permacol™, Medtronic) at a retromuscular sublay position for the prevention of incisional site hernias after loop-ileostomy closure. The main endpoints in this trial are infections at 30-day follow-up and the incidence of hernias clinically or on CT scan at 10 months after closure of the stoma. The secondary endpoints are other complications within 30 days of surgery graded with the Clavien-Dindo classification, reoperation rate, operating time, length of stay, quality of life measured with RAND-36, and incidence of hernia over a 5-year follow-up period. A total of 100 patients will be randomized in a 1:1 ratio. DISCUSSION: This is a pilot trial that will be undertaken to provide some novel evidence on the safety profile and efficiency of both synthetic mesh and biological implants for the prevention of incisional hernias after closure by temporary loop ileostomy. The hypothesis is that synthetic mesh is economical but equally safe and at least as effective as biological implants in hernia prevention and in contaminated surgical sites. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03445936 . Registered on 7 February 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Mäkäräinen-Uhlbäck E, Wiik H, Kössi J, et al. Preloop trial: study protocol for a randomized controlled trial. Trials. 2018. PMID: 30413211. doi:10.1186/s13063-018-2977-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。